Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03146845 · ClinicalTrials.gov registry record · NA
Evaluation Of An Advanced Borderless Dressing
A NA study of Diabetic Foot Ulcer and Pressure Ulcer, sponsored by Smith & Nephew.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 6
- Study locations
NCT03146845: Completed NA study of Diabetic Foot Ulcer and Pressure Ulcer, sponsored by Smith & Nephew.
NCT03146845 is a NA study of Diabetic Foot Ulcer and Pressure Ulcer that has completed, run by Smith & Nephew. The registered enrollment target is 40 participants, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (84% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03146845, a NA study of Diabetic Foot Ulcer and Pressure Ulcer, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study will gather preliminary clinical, health economic, and safety data on the treatment of chronic wounds with the ALLEVYN Life Non-Bordered dressing compared to standard of care treatment when used on a wound.
Primary Outcome
The primary objective was to estimate the effect of treatment with ALLEVYN Life Non-Bordered (ALNB) on Health-Related Quality of Life (HRQoL) in subjects with chronic ulcers, measured using the CWIS-PSDL scale, compared to subjects receiving standard care (SC) alone over a 6-week treatment period. The CWIS is a questionnaire to measure the impact of chronic wounds on patient health-related quality of life and identify areas of patient concern. The CWIS-PSDL score is transformed on to a 0-100 s
Conditions Studied
Interventions
- DEVICE ALLEVYN Life Non-Bordered
- DEVICE Standard Care
Study Locations (6)
California
- Center for Clinical Research - Martinez
- UCLA Medical Center - Sylmar
Arizona
- Titan Clinical Solutions - Phoenix
Louisiana
- Grace Research Ltd. - Shreveport
Missouri
- Wound Care Plus, LLC - Summit
Texas
- JPS Health Network - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2018-06-18 |
| Phase | NA |
What the finished NCT03146845 record still lists
NCT03146845 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which ALLEVYN Life Non-Bordered is the first listed.
NCT03146845 lists 6 locations in 5 states (California, Arizona, Louisiana).
Frequently Asked Questions
What is clinical trial NCT03146845 about?
NCT03146845 is a clinical study titled "Evaluation Of An Advanced Borderless Dressing". This study will gather preliminary clinical, health economic, and safety data on the treatment of chronic wounds with the ALLEVYN Life Non-Bordered dressing compared to standard of care treatment when used on a wound.
What is the current status of trial NCT03146845?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-06-15. Estimated completion is 2018-06-18.
What conditions does trial NCT03146845 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Pressure Ulcer, Leg Ulcer.
What interventions are being tested in trial NCT03146845?
The interventions under investigation include: ALLEVYN Life Non-Bordered (DEVICE), Standard Care (DEVICE).
Who is sponsoring clinical trial NCT03146845?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03146845 being conducted?
This trial has 6 study locations across Arizona, California, Louisiana, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03146845's enrollment target sits among peer trials
40 52nd of 67 higher than 15 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI